Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				309544 EudraCT No: 2005-003216-30, NCT00288249


2.		Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				91466 307975, NCT00313248


3.		ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-Independent Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				91500 307976, NCT00350051


4.		A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				91495 EudraCT: 2006-000067-29, 310101, NCT00359359


5.		Epothilone in Recurrent Glioblastoma Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 70				Other				ZK219477IV NCT00397072


6.		ZK219477 in Patients With Breast Cancer and Brain Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06-268 NCT00496379


7.		Phase II Trial Of ZK-EPO (ZK 219477) In Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				MCC-14965 USFIRB#105272, ZK219477, 108.0701, NCT00598507

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute